Stay updated on Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a minor update to the page’s template or content. This change does not modify the study details or user-facing information.
    Difference
    0.1%
    Check dated 2026-08-29T19:08:15.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page now shows a new site revision tag (v3.6.5) replacing the previous revision tag (v3.6.4), indicating a minor backend/UI update.
    Difference
    0.1%
    Check dated 2026-08-08T22:33:43.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    A new revision label, Revision: v3.6.4, was added and the previous label, Revision: v3.6.3, was removed, indicating an update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-07-25T12:36:58.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Update to revision label on the page from v3.6.2 to v3.6.3, indicating a new page version. This update likely includes minor behind-the-scenes changes without altering the displayed study details.
    Difference
    0.1%
    Check dated 2026-07-03T23:23:57.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-26T23:50:52.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Recruitment status now indicates no further participant recruitment; new help sections were added to assist users in reading, understanding, and joining studies, along with minor label formatting changes and a revision tag.
    Difference
    0.5%
    Check dated 2026-06-12T16:46:55.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial page.